Investor profile

EMBL Technology Fund II GmbH & Co. KG

EMBL Ventures GmbH · Multi-Country

EIF

Investment focus

Start with the fit.

EMBL Technology Fund II is an early-stage life-science fund managed by EMBL Ventures, based in Heidelberg, Germany, and associated with the European Molecular Biology Laboratory. It held a first close at EUR 40M (2011), typically invests EUR 3-5M as lead or co-lead across Europe, and is backed by the European Investment Fund. Portfolio companies include ViraTherapeutics and Luxendo.

AI Connector · MCP

Bring EUACC into your AI.

Choose your AI and follow the walkthrough. Your free EUACC account connects the two.

Illustrated walkthrough

Add EUACC to Claude

In Claude, open Customize, then Connectors.
Click + Add, then Add custom connector.
Name it EUACC, paste the link and click Continue.
Review the detected authentication settings and click Continue. Choose Sign in now, then Register automatically under OAuth client.
Click Add, then sign in with your free EUACC account and approve access.

Connector URLhttps://www.euacc.ai/api/mcp

Works on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.

On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.

Once connected, try this

Use EUACC to explore “Embl technology fund ii gmbh co kg” (https://www.euacc.ai/investors/embl-technology-fund-ii-gmbh-co-kg). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.

Your side of the introduction

Give investors a profile worth opening.

List your startup →